OVERVIEW

Revolutionizing Treatment for Melanoma - A Closer Look into the Potential of Immunotherapy is organized by Med Learning Group and will be held from Apr 04, 2019 - Apr 04, 2020.

Target audience:
This activity is designed to meet the educational needs of oncology nurses and other healthcare providers involved in the care of patients with melanoma.

Accreditation:
Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit(s)™.

Nursing Credit information:
CNE Credits: 1.0 ANCC Contact Hour(s)

Description:
This case-based activity will cover the treatment and management of patients with cancer who are treated with or are eligible for treatment with melanoma.

Learning objectives:
upon completion of the program, attendees should be able to:
• Describe the factors contributing to underdiagnosis/misdiagnosis/late diagnosis of melanoma in addition to the underlying pathogenesis and associated cellular pathways that drive metastatic melanoma.
• Discuss the mechanism of action of available immunotherapies for the treatment of advanced melanoma.
• Review current clinical trial data for immunotherapy agents in the treatment of unresectable and metastatic melanoma.
• Review strategies for recognizing and managing immune-based therapy related toxicities and discuss proper methodologies to relay these strategies.

Additional details will be posted as soon as they are available.